Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01210430 · ClinicalTrials.gov registry record · Early Phase 1
Local Vasoconstriction in Postural Tachycardia Syndrome
A Early Phase 1 study, sponsored by New York Medical College.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 74
- Enrollment target
NCT01210430 is a Early Phase 1 study that has completed, run by New York Medical College. The registered enrollment target is 74 participants.
The verdict
NCT01210430, a Early Phase 1 study, has completed, sponsored by New York Medical College.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 74 participants
- Enrollment target
Study Summary
The investigators study will determine how often blood flow regulation abnormalities and abnormalities of sympathetic regulation produced by nitric oxide, angiotensin-II, and oxidative stress occur in POTS and the mechanism(s) of POTS in individual patients. Specific causes for POTS may vary from patient to patient. Patients will be compared to healthy control subjects. There is a treatment arm with a medication (losartan) that reduces the binding of angiotensin and increases NO. If the investigators know the specific biochemical mechanism the investigators may be able to offer further specific treatments to specific patients.
Interventions
- DRUG Losartan
- DRUG Normal Saline
- DRUG Ascorbic Acid (Vitamin C)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2010-07 |
| Est. Completion | 2015-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01210430
The ClinicalTrials.gov registry entry for NCT01210430 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York Medical College, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Losartan is the first listed.
NCT01210430 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01210430 about?
NCT01210430 is a clinical study titled "Local Vasoconstriction in Postural Tachycardia Syndrome". The investigators study will determine how often blood flow regulation abnormalities and abnormalities of sympathetic regulation produced by nitric oxide, angiotensin-II, and oxidative stress occur in POTS and the mechanism(s) of POTS in individual patients. Specific causes for POTS may vary from pa...
What is the current status of trial NCT01210430?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 74 participants. The study started on 2010-07. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01210430?
The interventions under investigation include: Losartan (DRUG), Normal Saline (DRUG), Ascorbic Acid (Vitamin C) (DRUG).
Who is sponsoring clinical trial NCT01210430?
This trial is sponsored by New York Medical College, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.